Malgorzata E. Czyz

6/8 Mazowiecka Street
Lodz, LD 92215, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 65 publications

Cellular and Molecular Effects of Targeting the CBP/β-Catenin Interaction with PRI-724 in Melanoma Cells, Drug-Naïve and Resistant to Inhibitors of BRAFV600 and MEK1/2.

Cellular and Molecular Effects of Targeting the CBP/β-Catenin Interaction with PRI-724 in Melanoma Cells, Drug-Naïve and Resistant to Inhibitors of BRAFV600 and MEK1/2.

Journal: Cells

Published: September 17, 2025

Synergistic activity of S63845 and parthenolide to overcome acquired resistance to MEK1/2 inhibitor in melanoma cells: Mechanisms and therapeutic potential.

Synergistic activity of S63845 and parthenolide to overcome acquired resistance to MEK1/2 inhibitor in melanoma cells: Mechanisms and therapeutic potential.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: February 14, 2025

Therapeutic Potential of Natural Compounds to Modulate WNT/β-Catenin Signaling in Cancer: Current State of Art and Challenges.

Therapeutic Potential of Natural Compounds to Modulate WNT/β-Catenin Signaling in Cancer: Current State of Art and Challenges.

Journal: International journal of molecular sciences

Published: October 22, 2024

Exploring oncogenic roles and clinical significance of EZH2: focus on non-canonical activities.

Exploring oncogenic roles and clinical significance of EZH2: focus on non-canonical activities.

Journal: Therapeutic advances in medical oncology

Published: June 20, 2024

Pro-Apoptotic Activity of MCL-1 Inhibitor in Trametinib-Resistant Melanoma Cells Depends on Their Phenotypes and Is Modulated by Reversible Alterations Induced by Trametinib Withdrawal.

Pro-Apoptotic Activity of MCL-1 Inhibitor in Trametinib-Resistant Melanoma Cells Depends on Their Phenotypes and Is Modulated by Reversible Alterations Induced by Trametinib Withdrawal.

Journal: Cancers

Published: August 22, 2023

Histone Deacetylases (HDAC) Inhibitor-Valproic Acid Sensitizes Human Melanoma Cells to Dacarbazine and PARP Inhibitor.

Histone Deacetylases (HDAC) Inhibitor-Valproic Acid Sensitizes Human Melanoma Cells to Dacarbazine and PARP Inhibitor.

Journal: Genes

Published: May 08, 2023

Trametinib-Resistant Melanoma Cells Displaying MITFhigh/NGFRlow/IL-8low Phenotype Are Highly Responsive to Alternating Periods of Drug Withdrawal and Drug Rechallenge.

Trametinib-Resistant Melanoma Cells Displaying MITFhigh/NGFRlow/IL-8low Phenotype Are Highly Responsive to Alternating Periods of Drug Withdrawal and Drug Rechallenge.

Journal: International journal of molecular sciences

Published: March 19, 2023

lncRNAs-EZH2 interaction as promising therapeutic target in cutaneous melanoma.

lncRNAs-EZH2 interaction as promising therapeutic target in cutaneous melanoma.

Journal: Frontiers in molecular biosciences

Published: February 20, 2023

BCL-G: 20 years of research on a non-typical protein from the BCL-2 family.

BCL-G: 20 years of research on a non-typical protein from the BCL-2 family.

Journal: Cell death and differentiation

Published: November 28, 2022

Extracellular Vesicles-Based Cell-Cell Communication in Melanoma: New Perspectives in Diagnostics and Therapy.

Extracellular Vesicles-Based Cell-Cell Communication in Melanoma: New Perspectives in Diagnostics and Therapy.

Journal: International journal of molecular sciences

Published: November 17, 2022

WNT/β-catenin signaling in hepatocellular carcinoma: The aberrant activation, pathogenic roles, and therapeutic opportunities.

WNT/β-catenin signaling in hepatocellular carcinoma: The aberrant activation, pathogenic roles, and therapeutic opportunities.

Journal: Genes & diseases

Published: July 15, 2022

Structural and Biofunctional Insights into the Cyclo(Pro-Pro-Phe-Phe-) Scaffold from Experimental and In Silico Studies: Melanoma and Beyond.

Structural and Biofunctional Insights into the Cyclo(Pro-Pro-Phe-Phe-) Scaffold from Experimental and In Silico Studies: Melanoma and Beyond.

Journal: International journal of molecular sciences

Published: April 11, 2022

Showing 1-12 of 65

Last Updated: 09/26/2026